Promethazine
From Wikipedia, the free encyclopedia
| Image:Promethazine.png | |
| Promethazine
| |
| Systematic (IUPAC) name | |
| N, N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine | |
| Identifiers | |
| CAS number | 60-87-7 |
| ATC code | D04AA10 R06AD02, R06AD05 |
| PubChem | 4927 |
| DrugBank | APRD00601 |
| Chemical data | |
| Formula | C17H20N2S |
| Mol. weight | 284.425 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 88% absorbed but after first-pass metabolism reduced to 25% absolute bioavailability |
| Protein binding | 93% |
| Metabolism | Hepatic glucuronidation and sulfoxidation |
| Half life | 16-19 hours |
| Excretion | Renal and biliary |
| Therapeutic considerations | |
| Pregnancy cat. | |
| Legal status | |
| Routes | Oral, rectal, IV, IM |
Promethazine is a first-generation H1 receptor antagonist antihistamine and antiemetic medication. It is a prescription drug in the United States, but is available over the counter in the United Kingdom, Switzerland, and many other countries (brand names Phenergan® and Promethegan®).
Promethazine also has strong anticholinergic and sedative effects. Previously it was used as an antipsychotic, although it is generally not administered for this purpose now; promethazine has only approximately 1/10 of the antipsychotic strength of chlorpromazine.
Contents |
[edit] Indications
- As sedative/hypnotic
- For preoperative sedation and to counteract postnarcotic nausea
- As antiallergic medication to combat hay fever, allergic rhinitis, etc. To treat allergic reactions it can be given alone or in combination with oral decongestants like (pseudo-)ephedrine.
- Together with codeine or dextromethorphan against cough
- It can be used to increase the activity of opioids. It allows lower opioid doses and decreases their emetic properties.
- For severe Morning sickness - as an older drug with a greater experience of use during pregnancy, it is generally preferred to newer agents.
- As a motion sickness or seasickness medication. Commonly known as the "Coast Guard cocktail" when used with Ephedrine or Pseudoephedrine.
[edit] Contraindications
- Promethazine should not be given to children under two years of age; there is potential for fatal respiratory depression in this age group.
- Hypersensitivity to Phenothiazines
- Closed angle glaucoma
- Intoxication with alcohol or other central depressants
- Severe hypotension or shock
- Coma due to any reason
- Severely impaired liver function
- Urine hesitancy due to enlargement of the prostate gland
[edit] Side effects
Typical side effects are:
- Also extremely rare but most serious malignant neuroleptic syndrome
- Blurred vision
- Confusion in the elderly
- Drowsiness, dizziness, fatigue, more rarely vertigo
- Dry mouth
- Seizures (extremely rare)
- Respiratory depression in patients under age of 2 and in those with severely compromised pulmonal function
[edit] Dosage
Depending on disease and clinical condition (age, liver function):
- Mild to moderate cases of agitation: 25–50 mg orally, 3 to 4 times daily
- Insomnia: depending upon severity, 25–100 mg orally at bedtime
In pediatric patients doses as low as 5–10 mg, 3 times daily may suffice. For precise dosing syrup forms exist.
As an anti-emetic:
- Adult: 6.25 mg IV, or 12.5 mg IM
- Pediatric (greater than 2 years old): 0.25 mg/kg IV/ IM
[edit] Laboratory examinations
All patients should have their blood pressure measured frequently. During long-term therapy, blood cell counts, liver function studies, EKG, and EEG are recommended. The intervals should be determined according to the risk profile of the patient.
[edit] External links
- Letter from Wyeth Pharmaceuticals to practitioners regarding use of Phenergan in under twos. (PDF format)
[edit] References
- Basic and Clinical Pharmacology, 9th ed (2004). Katzung, Bertram G. pp. 264–265.
hu:Prometazin nl:Promethazine nn:Prometazin pl:Prometazyna ru:Дипразин sv:Prometazin th:โปรเมทาซีน zh:鹽酸異丙嗪

